Welcome to our dedicated page for Simulations Plus SEC filings (Ticker: SLP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
For investors following the niche world of pharmaceutical modeling software, Simulations Plus disclosures are a goldmine—yet finding R&D spending trends or segment revenue inside a dense filing can be daunting. Whether you’re searching for “Simulations Plus quarterly earnings report 10-Q filing” before an update, or need “Simulations Plus proxy statement executive compensation” details to benchmark management incentives, our page brings every document to your screen in seconds.
Stock Titan’s platform pairs real-time EDGAR feeds with AI-powered summaries, so “Simulations Plus SEC filings explained simply” is more than a promise. Our algorithms surface key metrics—software license growth, consulting backlog, new ADMET model releases—and flag “Simulations Plus 8-K material events explained” the moment they post. You can review “Simulations Plus insider trading Form 4 transactions” or set alerts for “Simulations Plus Form 4 insider transactions real-time” to monitor when executives buy or sell shares. Need deeper context? Click once and you’re “understanding Simulations Plus SEC documents with AI” as complicated accounting notes are distilled into plain language.
- “Simulations Plus annual report 10-K simplified” highlights long-term revenue drivers and R&D capitalization choices.
- “Simulations Plus earnings report filing analysis” breaks down quarter-over-quarter operating margin movements.
- “Simulations Plus executive stock transactions Form 4” lists every option exercise alongside historical price graphs.
From the initial S-1 to the latest 10-K, every filing type is archived, searchable, and enriched with expert commentary. Save hours locating segment data, assess insider sentiment before material announcements, and compare performance across years—all in one place.
Simulations Plus (SLP) reported a Form 4 showing Director Lisa LaVange received 1,771 shares of common stock on 11/03/2025 as independent director compensation under the company’s 2021 Equity Incentive Plan at a stated price of $0. Following this grant, she beneficially owns 10,834 shares, held directly.
Simulations Plus (SLP): insider stock grant reported. A joint Form 4 shows a director and 10% owner acquired 1,771 shares of common stock on 11/03/2025 at $0, recorded as an “A” code transaction. The filing cites stock granted as independent director compensation under the 2021 Equity Incentive Plan.
Following the grant, the reporting person’s beneficial ownership is 3,288,002 shares, held directly. The form was filed by more than one reporting person.
Simulations Plus (SLP) reported an insider equity grant. Director Daniel L. Weiner acquired 1,771 shares of common stock on 11/03/2025 as a stock grant under the company’s 2021 Equity Incentive Plan.
The reported transaction was coded as an acquisition at a grant price of $0, reflecting independent director compensation. Following the grant, Weiner beneficially owned 12,654 shares, held directly.
Simulations Plus, Inc. (SLP) reported an insider transaction on Form 4. Director John Kenneth Paglia acquired 1,771 shares of common stock on November 3, 2025, described as “stock granted as independent director compensation” under the company’s 2021 Equity Incentive Plan.
The filing lists a transaction price of $0 per share for the grant. After this award, Paglia beneficially owned 10,696 shares, held directly.
Simulations Plus (SLP)1,771 shares of common stock at $0 as independent director compensation under the company’s 2021 Equity Incentive Plan.
Following the grant, Evans beneficially owns 13,280 shares, held directly. This filing reflects routine director compensation rather than an open‑market purchase.
Simulations Plus, Inc. (SLP) furnished an 8-K announcing a press release with preliminary operational results for its fourth fiscal quarter ended August 31, 2025, and providing guidance and estimates for the fiscal year ending August 31, 2026.
The information under Items 2.02 and 7.01, and Exhibit 99.1, is furnished and not filed, and is not incorporated by reference except as expressly stated. The company also included a customary caution regarding forward-looking statements.
Simulations Plus (SLP)50,000 stock options to purchase common stock at an exercise price of $16.02 per share on 10/16/2025. The options expire on 10/15/2035 and were reported as a direct holding following the transaction.
The award vests over three years: 40% on the first anniversary, then 30% on each of the second and third anniversaries. The filing reflects a routine compensation grant under which the number of derivative securities beneficially owned after the transaction is 50,000.
Simulations Plus (SLP) reported an insider equity grant: its EVP/CFO received 32,500 stock options at an exercise price of $16.02 on 10/16/2025.
The options expire on 10/15/2035 and vest in four equal annual installments, with one fourth vesting on each anniversary of the grant date. Following this grant, the reporting person holds 32,500 derivative securities directly.
Simulations Plus (SLP)27,500 stock options on 10/16/2025 with an exercise price of $16.02 per share.
The options vest in four equal annual installments on each anniversary of the grant date and expire on 10/15/2035. Following the transaction, 27,500 derivative securities were beneficially owned directly.
Simulations Plus, Inc. (SLP) reported an insider equity award. A Form 4 discloses that Chief Revenue Officer John Anthony DiBella received stock options to purchase 27,500 shares at an exercise price of $16.02 on 10/16/2025.
The options expire on 10/15/2035 and vest in four equal annual installments, with one-fourth vesting on each anniversary of the grant date. Following the reported transaction, 27,500 derivative securities are beneficially owned directly.